JNJ-26481585

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNJ-26481585, covering 2012-09-14 to 2012-09-17. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. [Phase 1]

See pricing